Women and Diabetes: Preventing Heart Disease in a New Era of Therapies
Despite major advances in cardiovascular research over the past decade, women with type 2 diabetes have a high risk of cardiovascular events. Several factors contribute to the poor prognosis for women, including higher levels of frailty and comorbidities, but their cardiovascular risk is underestima...
Guardado en:
Autores principales: | Giuseppe Galati, Pierre Sabouret, Olga Germanova, Deepak L Bhatt |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Radcliffe Medical Media
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ec4ff1ff8efb43c3b5eb45f3380f1784 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Baroreflex Activation Therapy for Resistant Hypertension and Heart Failure
por: Anna Meta Dyrvig Kristensen, et al.
Publicado: (2020) -
Sodium–Glucose Cotransporter-2 Inhibitors and Heart Failure Prevention in Type 2 Diabetes
por: Muhammad Shahzeb Khan, et al.
Publicado: (2019) -
Heart failure and central sleep apnea in the era of implantable recorders
por: Irina Cabac-pogorevici, et al.
Publicado: (2021) -
A New Era in Zero X-ray Ablation
por: Giuseppe Mascia, et al.
Publicado: (2020) -
Hyperkalemia and Renin–Angiotensin–Aldosterone System Inhibitors Dose Therapy in Heart Failure With Reduced Ejection Fraction
por: Giuseppe MC Rosano, et al.
Publicado: (2019)